A
CAPR icon

AlphaQuest’s Capricor Therapeutics CAPR Stock Holding History

AlphaQuest’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,056
Closed -$867K – 335
2025
Q4 		$867K Buy
30,056
+31
+0.1% +$405 0.05% 506
2025
Q3 		$216K Buy
30,025
+23,974
+396% +$177K 0.01% 1368
2025
Q2 		$60.1K Sell
6,051
-758
-11% -$8.01K 0.01% 1587
2025
Q1 		$64.6K Buy
6,809
+1,133
+20% +$15.7K 0.01% 1453
2024
Q4 		$78.3K Buy
+5,676
New +$99.5K 0.01% 1172

Other funds holding CAPR

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JHC
Jones Hill Capital New York $470M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AlphaQuest's CAPR Position: Q1 2026 in Review

AlphaQuest sold out of Capricor Therapeutics (CAPR) in Q1 2026, closing a stake of 30,056 shares — an estimated $867K sold.

AlphaQuest first reported a position in CAPR in Q4 2024 and held it in 5 quarters. The position peaked at $867K in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • AlphaQuest reported no remaining Capricor Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 30,056 Capricor Therapeutics shares in Q1 2026, an estimated $867K.
  • AlphaQuest first reported a position in Capricor Therapeutics in Q4 2024 and held it in 5 quarters.
  • AlphaQuest's Capricor Therapeutics position peaked at $867K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.